Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Hofseth Biocare ASA ( (HOFBF) ).
Hofseth Biocare ASA announced a reduction in shareholding through Bonafide Funds, which resulted from the expiration of a mandate in the Bonafide Investment Fund – HBC I. The liquidation finalized on February 18, 2025, led to shares being delivered directly to fund investors, altering the company’s voting rights distribution.
More about Hofseth Biocare ASA
Hofseth Biocare ASA is a Norwegian company operating in the biotechnology industry, focusing on developing high-value ingredients and products derived from fish. The company primarily targets the health and nutrition sectors, offering bioactive peptides, proteins, and oils.
Average Trading Volume: 21,200
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $97.39M
Learn more about HOFBF stock on TipRanks’ Stock Analysis page.
